-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market
3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
We're in the midst of a bear market. That's something investors haven't seen in quite some time. While many stocks are getting crushed, it does create an opportunity for patient buyers, especially with top blue-chip stocks to buy.
While some may say it's irresponsible to buy in an environment like this, I think it's irresponsible for long-term investors not to be buying. At the very least, investors should be putting together a list of stocks they want to own and at what price they want to own them at.
I've been doing just that, accumulating a list of companies that have high-quality businesses but have seen their stock price come under pressure. In fact, let's look at some blue-chip stocks to buy that are tapping into a hidden bull market. Or, at least a bull market that's flying under the radar.
JNJ Johnson & Johnson $165.54 CAH Cardinal Health $66.02 ENPH Enphase Energy $290.04Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) is one of the top blue-chip stocks to buy. Shares are down just 2.5% so far this year and are only 11% off the all-time high. By contrast, the S&P 500 is down about 23% so far in 2022 and is 23.5% below its all-time high.
Despite turmoil in bonds, stocks and now currencies, J&J continues to chug along well. Admittedly, this multinational company will likely experience some currency pressures that eat into its margins. However, by and large, its business has been consistent.
Estimates may call for low single digit earnings and revenue growth this year. Still, investors are accumulating this stock for its dependability and durability. Case in point, the company just announced a new $5 billion buyback plan and reaffirmed its full-year outlook.
Admittedly, there's nothing too incredible about its outlook (as consensus estimates suggest), but to come out at a time like this and commit $5 billion to the buyback says something. That is, JNJ management is talking the talk and walking the walk.
Then there's the fact that Johnson & Johnson has raised its dividend in 59 straight years. That's another example of discipline and consistency.
Cardinal Health (CAH)
Healthcare is great because regardless of the economy or stock market, the population needs to take care of itself. If you have a medical emergency, you're going to the hospital regardless of where the S&P 500 is trading.
Like JNJ, Cardinal Health (NYSE:CAH) has found itself in a favorable position. The stock hit new multi-year highs earlier this month and is down "just" 9.5% from those highs after the recent pullback. Further, shares are actually up 27.5% on the year.
Cardinal Health is fresh off a monstrous reaction to earnings, after revenue grew more than 10% year over year and beat expectations by more than $2 billion. The stock yields 2.95% and management has raised its dividend for the last 27 years.
Lastly, analysts expect about 9% revenue growth this year, and while they expect just 4% growth in FY 2024, consensus earnings expectations call for 4.3% growth this year but a huge acceleration up to 17% growth in FY 2024.
Enphase Energy (ENPH)
Enphase Energy (NYSE:ENPH) continues to deliver the goods.
While the stock market is struggling near its 2022 lows, solar stocks are, for the most part, hanging in there. In fact, most continue to trade well in what has become a rare combination of strong fundamentals and bullish technicals.
The bullish party really got started in late July, when Enphase beat on earnings and revenue estimates, while growing sales 67% year over year. Then guidance came well above analysts' expectations. It was a lights out quarter with First Solar (NASDAQ:FSLR) delivering dazzling earnings results, as well.
As it stands now, Enphase is forecast to grow revenue 62% this year and 33.5% next year. On the earnings front, analysts expect 70% growth this year and 22% growth next year. At a time where we're staring down a recession and barreling through a bear market, Enphase continues to generate strong growth and maintain strong technicals. Of course, it helps that the stock is up a whopping 50% year to date.
On the date of publication, Bret Kenwell did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.
The post 3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市场新闻、股票建议和交易提示
We're in the midst of a bear market. That's something investors haven't seen in quite some time. While many stocks are getting crushed, it does create an opportunity for patient buyers, especially with top blue-chip stocks to buy.
我们正处于熊市之中。这是投资者已经很长一段时间没有看到的情况了。虽然许多股票正在遭受重创,但它确实为耐心的买家创造了机会,尤其是顶级蓝筹股的买入。
While some may say it's irresponsible to buy in an environment like this, I think it's irresponsible for long-term investors not to be buying. At the very least, investors should be putting together a list of stocks they want to own and at what price they want to own them at.
虽然有些人可能会说在这样的环境下买入是不负责任的,但我认为对长期投资者来说是不负责任的不去买东西。至少,投资者应该列出一份他们想要持有的股票的清单,以及他们想以什么价格持有这些股票。
I've been doing just that, accumulating a list of companies that have high-quality businesses but have seen their stock price come under pressure. In fact, let's look at some blue-chip stocks to buy that are tapping into a hidden bull market. Or, at least a bull market that's flying under the radar.
我一直在这么做,积累了一份拥有高质量业务但股价承压的公司的名单。事实上,让我们来看看一些正在利用隐藏的牛市买入的蓝筹股。或者,至少是一个在雷达下飞行的牛市。
Johnson & Johnson (JNJ)
强生(JNJ)
Johnson & Johnson (NYSE:JNJ) is one of the top blue-chip stocks to buy. Shares are down just 2.5% so far this year and are only 11% off the all-time high. By contrast, the S&P 500 is down about 23% so far in 2022 and is 23.5% below its all-time high.
强生(纽约证券交易所代码:JNJ)是值得买入的顶级蓝筹股之一。今年到目前为止,该公司股价仅下跌了2.5%,仅比历史高点低了11%。相比之下,标准普尔500指数2022年迄今下跌约23%,较历史高点低23.5%。
Despite turmoil in bonds, stocks and now currencies, J&J continues to chug along well. Admittedly, this multinational company will likely experience some currency pressures that eat into its margins. However, by and large, its business has been consistent.
尽管债券、股票以及现在的货币市场出现动荡,但强生继续保持着良好的发展势头。诚然,这家跨国公司可能会遭遇一些汇率压力,侵蚀其利润率。然而,总的来说,它的业务一直是始终如一的。
Estimates may call for low single digit earnings and revenue growth this year. Still, investors are accumulating this stock for its dependability and durability. Case in point, the company just announced a new $5 billion buyback plan and reaffirmed its full-year outlook.
据估计,今年的收益和收入可能会出现较低的个位数增长。尽管如此,投资者仍在因其可靠性和耐用性而积累这只股票。例如,该公司刚刚宣布了一项新的50亿美元回购计划,并重申了全年展望。
Admittedly, there's nothing too incredible about its outlook (as consensus estimates suggest), but to come out at a time like this and commit $5 billion to the buyback says something. That is, JNJ management is talking the talk and walking the walk.
诚然,它的前景并不是太令人难以置信(正如普遍估计的那样),但在这样的时候出来,并承诺50亿美元用于回购,这说明了一些问题。也就是说,JNJ管理层正在说到做到。
Then there's the fact that Johnson & Johnson has raised its dividend in 59 straight years. That's another example of discipline and consistency.
然后是强生连续59年提高股息的事实。这是纪律和一致性的又一个例子。
Cardinal Health (CAH)
基本健康(CAH)
Healthcare is great because regardless of the economy or stock market, the population needs to take care of itself. If you have a medical emergency, you're going to the hospital regardless of where the S&P 500 is trading.
医疗保健是伟大的,因为无论是经济还是股市,人们都需要照顾自己。如果你有医疗紧急情况,无论你在哪里,你都会去医院标准普尔500指数就是交易。
Like JNJ, Cardinal Health (NYSE:CAH) has found itself in a favorable position. The stock hit new multi-year highs earlier this month and is down "just" 9.5% from those highs after the recent pullback. Further, shares are actually up 27.5% on the year.
像JNJ一样,康德乐(纽约证券交易所代码:CAH)发现自己处于有利地位。本月早些时候,该股创下多年来的新高,在最近的回调后,仅较这些高点下跌了9.5%。此外,股票实际上是向上同比增长27.5%。
Cardinal Health is fresh off a monstrous reaction to earnings, after revenue grew more than 10% year over year and beat expectations by more than $2 billion. The stock yields 2.95% and management has raised its dividend for the last 27 years.
红衣主教健康公司刚刚对收益做出了惊人的反应,该公司收入同比增长超过10%,超出预期超过20亿美元。该股收益率为2.95%,管理层在过去27年里一直在提高股息。
Lastly, analysts expect about 9% revenue growth this year, and while they expect just 4% growth in FY 2024, consensus earnings expectations call for 4.3% growth this year but a huge acceleration up to 17% growth in FY 2024.
最后,分析师预计今年收入增长约9%,虽然他们预计2024财年仅增长4%,但普遍的收益预期是今年增长4.3%,但2024财年增长将大幅加快,最高可达17%。
Enphase Energy (ENPH)
相态能量(ENPH)
Enphase Energy (NYSE:ENPH) continues to deliver the goods.
相态能量(纽约证券交易所股票代码:ENPH)继续发货。
While the stock market is struggling near its 2022 lows, solar stocks are, for the most part, hanging in there. In fact, most continue to trade well in what has become a rare combination of strong fundamentals and bullish technicals.
虽然股市在2022年的低点附近举步维艰,但太阳能类股在很大程度上仍坚挺在那里。事实上,在强劲的基本面和看涨的技术面罕见的组合中,大多数股票继续表现良好。
The bullish party really got started in late July, when Enphase beat on earnings and revenue estimates, while growing sales 67% year over year. Then guidance came well above analysts' expectations. It was a lights out quarter with First Solar (NASDAQ:FSLR) delivering dazzling earnings results, as well.
看涨狂欢真正开始于7月下旬,当时安进的收益和收入预期都超过了预期,销售额同比增长了67%。当时的指引远远超出了分析师的预期。这是一个灯火通明的季度第一个太阳能(纳斯达克:FSLR)也发布了令人眼花缭乱的收益业绩。
As it stands now, Enphase is forecast to grow revenue 62% this year and 33.5% next year. On the earnings front, analysts expect 70% growth this year and 22% growth next year. At a time where we're staring down a recession and barreling through a bear market, Enphase continues to generate strong growth and maintain strong technicals. Of course, it helps that the stock is up a whopping 50% year to date.
按照目前的情况,Enval预计今年的收入将增长62%,明年将增长33.5%。在盈利方面,分析师预计今年将增长70%,明年将增长22%。在我们正紧盯着衰退和熊市的时刻,安进继续带来强劲的增长,并保持强劲的技术面。当然,今年到目前为止,该股上涨了50%,这是有帮助的。
On the date of publication, Bret Kenwell did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
截至发稿之日,布雷特·肯威尔并未(直接或间接)持有本文所述证券的任何头寸。本文中表达的观点是作者的观点,受InvestorPlace.com发布指南的约束。
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.
布雷特·肯威尔是未来蓝筹股的经理和作者,他的推特是@BretKenwell。
The post 3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market appeared first on InvestorPlace.
帖子3蓝筹股购买进入隐藏的牛市最先出现在InvestorPlace上。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧